# Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

> **NCT03834272** · PHASE1,PHASE2 · COMPLETED · sponsor: **Lumicell, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Peritoneal Metastases

## Interventions

- **COMBINATION_PRODUCT:** LUM Imaging System

## Key facts

- **NCT ID:** NCT03834272
- **Lead sponsor:** Lumicell, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-08-19
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03834272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03834272, "Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03834272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*